Immunomodulatory effects of peptide T on Th 1/Th 2 cytokines

International Journal of Immunopharmacology

Volumn 21, Issue 9, 1999, Pages 609-615

  Raychaudhuri, Siba P ^a   Farber, Eugene M ^a   Raychaudhuri, Smriti K ^b  

^a Psoriasis Research Institute   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; PEPTIDE T;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ADULT; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PEPTIDE T; PSORIASIS;

EID: 0032856047     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00041-7     Document Type: Article

References (30)

1. Asadullah K., Sterry W., Stephanek K., Jasulaitis D., Leupold M., Audring H., Volk H-D., Docke W-D. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101:1998;783-794.
2. Chang J.C.C., Smith L.R., Froning K.J. Persistence of T-cell clones in psoriatic lesions. Arch. Dermatol. 133:1997;703-708.
3. D'Andrea A., Aste-Amezaga M., Valiante N.M.M.A.X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1993;1041-1048.
4. De Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., De Varies J.E. Interleukin 10 (IL-10) inhibits human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
5. Farber E.M., Cohen E.N., Trozak D., Wilkinson D.I. Peptide T improves psoriasis when infused into lesions in nanogram amounts. J. Amer. Acad. Dermatol. 25:1991;658-664.
6. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 in hibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
7. Fuchs A.C., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Radwanski E., Affrime M.B. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J. Clin. Immunol. 16:1996;291-303.
8. Jegasothy B.V., Ackerman C.D., Todo S., Fung J.J., Abu-Elmagd K., Starzl T.E. Tacrolimus (FK506): a new therapeutic agent for severe recalcitrant psoriasis. Arch. Dermatol. 128:1992;781-785.
9. Johansson O., Hilliges M., Talme T., Marcusson J.A., Wetterberg L. Speculations around the mechanism behind the action of peptide T in the healing process of psoriasis. A minireview. Acta. Derm. Venereol. 73:1993;401-403.
10. Johansson O., Hilliges M., Talme T., Marcusson J.A., Wetterberg L. Somatostatin immunoreactive cells in lesional psoriatic human skin during peptide T treatment. Acta. Derm. Venereol. 74:1994;106-109.
11. Li J., Ireland G.W., Farthing P.M., Thornhill M.H. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J. Invest. Dermatol. 106:1996;661-666.
12. Marcusson J.A., Wetterberg L. Peptide T in the treatment of psoriasis and psoriatic arthritis. Acta. Derm. Venerol. 69:1989;86-88.
13. Nickoloff B.J. The cytokine network in psoriasis. Arch. Dermatol. 127:1991;871-884.
14. Ockenfels H.M., Wagner S.N., Kemi-mass C., Funk R., Nussbaum G., Goos M. Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch. Dermatol. Res. 288:1996;173-178.
15. Piquet P.F., Gran G.E., Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am. J. Pathol. 136:1990;103-110.
16. Prinz J.C., Gross B., Vollmer S., Trommler P., Strobel I., Meurer M., Plewig G. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur. J. Immunol. 24:1994;593-598.
17. Raychaudhuri S.K., Raychaudhuri S.P., Farber E.M. Anti-chemotactic activities of peptide T: a possible mechanism of actions for its therapeutic effects on psoriasis. Int. J. Immunopharmacol. 20:1999;661-667.
18. Raychaudhuri S.P., Jiang W-Y., Farber E.M., Schall T., Ruff M., Pert C. Identification of high levels of RANTES in the Psoriatic Keratinocytes. Acta Derm. Venereol. 79:1999;9-11.
19. Ruff M.R., Halberg P.L., Hill J.M. Peptide T 4-8 is core HIV envelope sequence required for CD4 receptor attachment. Lancet. ii:1987;751.
20. Ruff M.R., Pert C.B., Bradley B., Loveless M., Darmanandra S., Philips T.M. An analysis of fifteen cytokine changes in adult HIV patients receiving peptide T for seven weeks. AIDS Res. Hum. Retrovir. 11 S1:1995;. Abstr 393.
21. Ruff M.R., Rone J.R., Sandler B., Lumpkin M.D., Pert C.B. A modified octapeptide from HIV envelope gp120 potently inhibits RANTES chemotaxis of CCR5-expressing cells. (abstr 330) Role of Chemokines in Disease. Proceedings of the Keystone Symposium, April. 1997.
22. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine. 3:1991;165-183.
23. Schlaak J.F., Hermann E., Gallati H., Meyer Zum Buschenfelde K.H., Fleischer B. Differential effects of IL-10 on proliferation and cytokine production of human gamma/delta and alpha/beta T cells. Scand. J. Immunol. 39:(2):1994;209-215.
24. Shakhov A.N., Woerly G., Car B.D., Ryffel B. Interferon-gamma enhances tumor necrosis factor-alpha production by inhibiting early phase interleukin-10 transcription. Eur. Cyt. Network. 7:1996;741-750.
25. Takashima A., Morita A. Genomic, phenotypic, and functional analyses of T cells in patients with psoriasis undergoing systemic cyclosporine A treatment. J. Invest. Dermatol. 96:1991;376-382.
26. Talme T., Rozell B.L., Sundquist K.G., Wetterberg L., Marcusson J.A. Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment. Arch. Dermatol. Res. 287:1995;533-557.
27. Uyemura K., Yamamura M., Fivenson D.F., Modlin R.L., Nickoloff B.J. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell mediated response. J. Invest. Dermatol. 101:1993;701-705.
28. Valdimarsson H., Baker B.S., Jonsdottir I. Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol. Today. 7:1986;256-259.
29. Wetterberg L., Alexius B., Saaf J. Peptide T in treatment of AIDS. Lancet. i:1987;159.
30. Wolfer L.U., Goerdt S., Shroder K., Zouboulis C.C., Orfanos C.E. Interferon-alpha induced psoriasis. Hautarzt. 47:1996;124-128.